Skin disorders
23 results
Applied filters
Good governance when implementing ustekinumab biosimilar
29 July 2025Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
Hydrogen peroxide 1% cream for impetigo
27 January 2025SPS protocol template (registered pharmacists and in a registered pharmacy) and PGD template for the supply of hydrogen peroxide 1% cream for localised impetigo
Malathion for scabies
27 November 2025SPS PGD template for supply of malathion for the treatment of scabies in specified patient groups.
Permethrin for scabies
27 November 2025SPS PGD template for supply of permethrin for the treatment of scabies in specified patient groups.
Preparing to use omalizumab biosimilar
20 January 2026One omalizumab biosimilar (Omlyclo) is available and other biosimilars are in development. We offer general information and implementation advice.
Preparing to use ustekinumab biosimilar
29 July 2025Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
The licence and supporting evidence for omalizumab biosimilar
21 January 2026One omalizumab biosimilar is currently available: Omlyco. Learn about the licensed indications, available preparations, supporting evidence and key differences.
The licence and supporting evidence for ustekinumab biosimilars
29 July 2025Ustekinumab biosimilars (Pyzchiva, Steqeyma, Uzpruvo, Wezenla) are licensed. Learn about indications, formulations, supporting evidence and differences.
Treating impetigo topically during breastfeeding
21 March 2024Fusidic acid, hydrogen peroxide or mupirocin can be used topically during breastfeeding. Recommendations apply to full term and healthy infants.
Treating lice during breastfeeding
31 May 2024Wet combing, dimeticone, malathion or permethrin can be used during breastfeeding; choice will depend on the indication. Other treatments can be considered.